After a heart attack, the body rapidly floods the injured heart with neutrophils—white blood cells that help repair damage ...

After a heart attack, the body rapidly floods the injured heart with neutrophils - white blood cells that help repair damage ...

After a heart attack, the body rapidly floods the injured heart with neutrophils — white blood cells that help repair damage but can ...

This highly conserved protein is largely overlooked by researchers but is at the core of immune functions, helping regulate ...

European Commercialization will be Led by X4 Pharmaceuticals’ Partner, Norgine - - Global, Pivotal Phase 3 Clinical Trial ...

Achieved $18.5 million in first quarter of 2026 net product revenues for IBTROZI® (taletrectinib); majority of the approximately 200 patients started on IBTROZI in ...

Oral agent in second-line more than doubled median PFS in patients with ESR1 muta ...

Norgine, a leading European specialty pharmaceutical company, today announced that the European Commission (EC) has granted ...

Researchers at Dresden University Hospital may have discovered a new therapeutic approach for treating myelodysplastic ...

We summarized existing research on weight loss medications in rheumatic disease and their potential for improving quality of ...

If future trials continue to show positive results, the drug may provide a pain-relief option that lacks the risks of long-term NSAID use.

The neutrophil-to-lymphocyte ratio (NLR) is gaining ground as a quick, affordable way to understand inflammation’s role in disease. Elevated NLR has been linked to worse outcomes in chronic, metabolic ...